NTRR (Neutra) ROE % Adjusted to Book Value: 0.00% (As of Apr. 2024)


What is Neutra ROE % Adjusted to Book Value?

Neutra NTRR ROE % Adjusted to Book Value is 0.00% as of Apr. 2024.

Neutra's ROE % for the quarter that ended in Apr. 2024 was 0.00%. Neutra's PB Ratio for the quarter that ended in Apr. 2024 was N/A. Neutra's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2024 was N/A.


Neutra ROE % Adjusted to Book Value Related Terms


Neutra ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Neutra's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neutra ROE % Adjusted to Book Value Chart

Neutra Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Neutra Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NTRR vs NXEN, PNXP, PLSH: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Neutra's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neutra's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Neutra's ROE % Adjusted to Book Value falls into.



Neutra ROE % Adjusted to Book Value Calculation

Neutra's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Neutra's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Neutra (NTRR) has a ROE % Adjusted to Book Value of 0.00% as of Apr. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neutra and its competitors.
Is Neutra's ROE % Adjusted to Book Value too high?
Neutra's current ROE % Adjusted to Book Value is 0.00%.
How does Neutra's ROE % Adjusted to Book Value compare to NXEN and PNXP?
Neutra's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neutra and its competitors. Neutra's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neutra stock overvalued right now?
Neutra (NTRR) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Neutra (NTRR), the current ROE % Adjusted to Book Value is 0.00% as of Apr. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neutra Business Description

Address 2500 CityWest Boulevard, Suite 150-161, Houston, TX, USA, 77042
Neutra Corp to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, It plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself.